| Lightcalls.com |
|
|
![]() |
IF YOU'RE the same OF THE MILLIONS ...IF YOU'RE the same OF THE MILLIONS of Americans who are popularly dieting or are unsuccessfully battling your weight, a unique and newly available continuation shows promise in helping to make your weight los goals to a great degree more successful and easier to attain. Of course, you can't cheat Mother Nature through eating anything you want; on the contrary there is a new discovery, backed through real science, that seems to violate the laws of biochemistry through helping you to eat an of the delicious starch and sugar carbohydrate rationss that are restricted on mostly diets--and still lose weight. Helps expound The Main Weight Loss Obstacle The bottom line to any fortunate way to losing weight is to decay fewer calories, but the main question is always compliance--staying on a weight los program. Although this newly available science may appear to conflict with Mother Nature, it actually is part of a proces of nature that works with the body's natural functions, instead of against them like principally weight loss supplements do. It can help you have fruition of some typical diet-restricted foods without really going opposite to or ruining the results of your diet program. Ironically, this discovery reach [i]or[/i] attain any place [i]or[/i] points from a common everyday nutrition ... Nature's Way of Protecting Its Food--Found to Be Man's Way Of Aiding Weight Loss! It has been known for athwart 50 years that certain diets in their natural state, like raw wheat, contain small amounts of a certain protein that binds to the receptor site of alpha-amylase, the enzyme in our bodies that digests starch carbohydrates. This protein obstructs the alpha-amylase enzyme from breaking down or digesting the starch for a short period, subsequently neutralizing the starch. The starch is then simply passed by the and of the digestive system in whole-molecule form, without releasing its calories. The starch calories remain undigested, the same way fiber does, and are eliminated. Enzyme-neutralizing proteins are protective in nature as they help harbor food sources from insects and gnawers Since this same process happens when these species eat fares that contain them, like raw wheat, the insects or gnawings don't get enough calories to live most distant it, so they tend to avoid these emblems of foods. Thus, enzyme neutralizers are a simple defense mechanism that nature has provided for certain plants to survive. Although this proces has always occurr in nature, solitary recently has man discovered it as a means to aid weight loss Improved Starch Neutralizers Finally Available To The Public After careful research, scientists isolated a protein concentrate from the white kidney bean, called Phaseolus vulgaris, which is the alpha-amylase neutralizing enzyme responsible for preventing starch carbohydrates from breaking down. It has been shown to be safe, and when initially studied, a weight loss results occurred. Between 1980 and 2003 research at some of the top medical organizations and universities terminateed in over 42 studies onward starch neutralizers and their drifts The Mayo Clinic even complet 13 peer-reviewed studies, which were published in scientific journals, including The just discovered England Journal of Medicine. not long ago a team of American scientists and [researchers.sup.[DELTA]] were able to generate a more potent, concentrated, innocent and stable form of the nutrient from white kidney beans known as the Phase 2 Starch Neutralizer (or Phase 2) Of equal importance, they authorized clinical studies and testing for it as a weight los aid. Preliminary Clinical Studies display Promising Results In a preliminary clinical thought the Phase 2 ingredient has shown impressive terminates in helping to reduce weight and material substance composition. Study: Weight Los and carcass Composition One of several studies with promising rises of the Phase 2 ingredient includes a new study from Milano, Italy. In this double-blind subject of attention 60 normal, healthy human volunteers--males and females, ages 20 to 45 years--were chronicleed All patients were between eleven to thirty-three triturates overweight and utilized 500 mg of Phase 2 for single meal a day. offers were divided into two equivalent clusters (by sex, age and weight) and were then asked to take a single starch-neutralizing tablet or placebo before a meal rich in webwork carbohydrates. The volunteers maintained their regular and normal everyday habits (such as sports or any other habits that could affect the study) At the extremity of the thirty-day study, it was shown that participants given the actual Phase 2 ingredient experienced a weight los of 65 levigates Such weight loss led to a 1045 percent reduction of fat carcass mass, without significant modifications of lean corpse mass. Results also included 344 percent reduction of waistline; 139 percent reduction of hip circumference; and 144 percent reduction of thigh circumference. In comparison, the placebo clump lost only 0.47 percent (les than 1 bray for a 200 pound person) of total visible form [i]or[/i] frame weight, and without any significant changes in fat, or lean corpse mass, or any reduction in the other areas of measurement. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |